APA (7th ed.) Citation

G, B., N, A., F, S., GN, S., S, K., U, I., . . . O, O. (2015). GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro. Human reproduction (Oxford, England), 30(12), 2912. https://doi.org/10.1093/humrep/dev257

Chicago Style (17th ed.) Citation

G, Bildik, et al. "GnRH Agonist Leuprolide Acetate Does Not Confer Any Protection Against Ovarian Damage Induced by Chemotherapy and Radiation in Vitro." Human Reproduction (Oxford, England) 30, no. 12 (2015): 2912. https://doi.org/10.1093/humrep/dev257.

MLA (9th ed.) Citation

G, Bildik, et al. "GnRH Agonist Leuprolide Acetate Does Not Confer Any Protection Against Ovarian Damage Induced by Chemotherapy and Radiation in Vitro." Human Reproduction (Oxford, England), vol. 30, no. 12, 2015, p. 2912, https://doi.org/10.1093/humrep/dev257.